Offer - Urjas Oil for just ₹ 1 X
Mycurit 3 Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Tuberculosis.
The right dosage of Mycurit 3 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Mycurit 3 Tablet include Dizziness, Difficulty breathing, Difficulty talking. Normally, these side effects of Mycurit 3 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Mycurit 3 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Mycurit 3 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Mycurit 3 Tablet related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Heart Disease must refrain from the use of Mycurit 3 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Mycurit 3 Tablet contraindications section.
Besides this, Mycurit 3 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Mycurit 3 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Mycurit 3 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mycurit 3 Tablet safe for pregnant women?
Mycurit may have some side effects during pregnancy. Pregnant women should discontinue the use of Mycurit, and talk to their doctor, if they notice any discomfort.
Is the use of Mycurit 3 Tablet safe during breastfeeding?
Mycurit can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mycurit 3 Tablet on the Kidneys?
Mycurit may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mycurit 3 Tablet on the Liver?
The liver can be affected by Mycurit. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Mycurit only after medical advice.
What is the effect of Mycurit 3 Tablet on the Heart?
Mycurit can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Mycurit 3 Tablet unless your doctor advises you to do so -
Is this Mycurit 3 Tablet habit forming or addictive?
Mycurit 3 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mycurit 3 Tablet can make you feel drowsy.
Is it safe?
Mycurit 3 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Mycurit 3 Tablet for mental disorders.
Interaction between Food and Mycurit 3 Tablet
You can take Mycurit 3 Tablet with food.
Interaction between Alcohol and Mycurit 3 Tablet
Consumption of alcohol and Mycurit 3 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited